lidocaine topical
| Drug Name | Form | Strength | Non-Formulary | Restricted | TX Sub | Notes |
|---|---|---|---|---|---|---|
| Lidoderm | FILM, EXTENDED RELEASE, TOPICAL | 5% | ||||
| Xylocaine | GEL WITH APPLICATOR, TOPICAL | 2% (Urojet) | ||||
| Duo-Trach | KIT, MUCOUS MEMBRANE | 4% (Duo-Trach) 160 mg/4 mL | ||||
| AneCream with Tegaderm | KIT, TOPICAL | 4% | ||||
| Xylocaine | OINTMENT, TOPICAL | 5% | ||||
| Xylocaine Viscous | SOLUTION, MUCOUS MEMBRANE | 2% | ||||
| Xylocaine | SOLUTION, TOPICAL | 4% |
| Per policy, orders for these non-formulary agents will be changed to formulary equivalents. | |
|---|---|
| Non-Formulary Agent | Formulary Equivalent |
| lidocaine (Xylocaine) oral spray | benzocaine (Hurricane) spray |
| lidocaine (Lidoderm) patch | 12 hrs on/12 hrs off; enter “Remove Patch” order in PowerChart |
| Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics | |
|---|---|
| Medication: | lidocaine viscous, topical |
| Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List: Second Edition (Table 1) | |
| Drug | ester local anesthetics |
| Risk/Rationale | Central nervous system depression, seizures, arrhythmia, death |
| Recommendation | Avoid oral application in younger than 2 yr |
| Quality of evidence: High, Strength of Recommendation: Strong | |